EDN1

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA031976

Antibody CAB032500

Antibody CAB037291

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Malignant cells showed weak to moderate cytoplasmic immunoreactivity. Most cases of malignant lymphomas, skin and lung cancers were negative.Colorectal, ovarian and endometrial cancers as well as a few cases of lymphomas and liver cancers showed weak to moderate cytoplasmic immunoreactivity with additional nuclear or membranous staining in some cases. Remaining cancers were generally negative.Most cancers displayed weak to moderate cytoplasmic positivity with additional membranous staining in several cases. Several carcinoids, renal and colorectal cancers along with a few breast, stomach, liver and pancreatic cancers were strongly stained. Many gliomas and lymphomas were negative.

Validation

Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data
Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data
Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected